BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 8623130)

  • 1. Circulating red cells usually remain of host origin after bone marrow transplantation for severe combined immunodeficiency.
    Brady KA; Cowan MJ; Leavitt AD
    Transfusion; 1996 Apr; 36(4):314-7. PubMed ID: 8623130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency.
    Buckley RH; Schiff SE; Schiff RI; Markert L; Williams LW; Roberts JL; Myers LA; Ward FE
    N Engl J Med; 1999 Feb; 340(7):508-16. PubMed ID: 10021471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multilineage hematopoietic engraftment after allogeneic peripheral blood stem cell transplantation without conditioning in SCID patients.
    Bielorai B; Trakhtenbrot L; Amariglio N; Rothman R; Tabori U; Dallal I; Golan H; Neumann Y; Reichart M; Kaplinsky C; Rechavi G; Toren A
    Bone Marrow Transplant; 2004 Aug; 34(4):317-20. PubMed ID: 15220954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haploidentical bone marrow stem cell transplantation in human severe combined immunodeficiency.
    Buckley RH; Schiff SE; Schiff RI; Roberts JL; Markert ML; Peters W; Williams LW; Ward FE
    Semin Hematol; 1993 Oct; 30(4 Suppl 4):92-101; discussion 102-4. PubMed ID: 7905667
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes of nonconditioned patients with severe combined immunodeficiency transplanted with HLA-identical or haploidentical bone marrow depleted of T cells with anti-CD6 mAb.
    Patel NC; Chinen J; Rosenblatt HM; Hanson IC; Brown BS; Paul ME; Abramson SL; Ritz J; Shearer WT
    J Allergy Clin Immunol; 2008 Dec; 122(6):1185-93. PubMed ID: 19084111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the european society for immunodeficiency.
    Bertrand Y; Landais P; Friedrich W; Gerritsen B; Morgan G; Fasth A; Cavazzana-Calvo M; Porta F; Cant A; Espanol T; Müller S; Veys P; Vossen J; Haddad E; Fischer A
    J Pediatr; 1999 Jun; 134(6):740-8. PubMed ID: 10356144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
    Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of tolerance after haplocompatible T-depleted bone marrow transplantation.
    Merino A; Dror Y; Benkerrou M; Colombe BW; Cowan MJ
    Bone Marrow Transplant; 1993 Nov; 12(5):483-8. PubMed ID: 8298559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT.
    Heimall J; Puck J; Buckley R; Fleisher TA; Gennery AR; Neven B; Slatter M; Haddad E; Notarangelo LD; Baker KS; Dietz AC; Duncan C; Pulsipher MA; Cowan MJ
    Biol Blood Marrow Transplant; 2017 Mar; 23(3):379-387. PubMed ID: 28068510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders.
    Knutsen AP; Wall DA
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):823-32. PubMed ID: 10329816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of natural killer cell killer Ig-like receptor alloreactivity on the outcome of bone marrow stem cell transplantation for severe combined immunodeficiency (SCID).
    Keller MD; Chen DF; Condron SA; Liu N; Reinsmoen NL; Buckley RH
    J Clin Immunol; 2007 Jan; 27(1):109-16. PubMed ID: 17191149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haploidentical peripheral blood and marrow stem cell transplantation in nine cases of primary immunodeficiency.
    Lanfranchi A; Verardi R; Tettoni K; Neva A; Mazzolari E; Pennacchio M; Pasic S; Ugazio AG; Albertini A; Porta F
    Haematologica; 2000 Nov; 85(11 Suppl):41-6. PubMed ID: 11268323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of multiple monoclonal serum immunoglobulins (multiclonal gammopathy) following both HLA-identical unfractionated and T cell-depleted haploidentical bone marrow transplantation in severe combined immunodeficiency.
    Kent EF; Crawford J; Cohen HJ; Buckley RH
    J Clin Immunol; 1990 Mar; 10(2):106-14. PubMed ID: 2338452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term chimerism and B-cell function after bone marrow transplantation in patients with severe combined immunodeficiency with B cells: A single-center study of 22 patients.
    Haddad E; Le Deist F; Aucouturier P; Cavazzana-Calvo M; Blanche S; De Saint Basile G; Fischer A
    Blood; 1999 Oct; 94(8):2923-30. PubMed ID: 10515898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies.
    Filipovich AH; Shapiro RS; Ramsay NK; Kim T; Blazar B; Kersey J; McGlave P
    Blood; 1992 Jul; 80(1):270-6. PubMed ID: 1611094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total body irradiation and bone marrow transplantation for immunodeficiency disorders in young children.
    Halberg FE; Wara WM; Weaver KE; Wara DW; Ablin AR; Matthay KK; Mentzer WC; O'Leary MC; Cowan MJ
    Radiother Oncol; 1990; 18 Suppl 1():114-7. PubMed ID: 2247633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysfunctional cytokine production by host-reactive T-cell clones isolated from a chimeric severe combined immunodeficiency patient transplanted with haploidentical bone marrow.
    Bacchetta R; Parkman R; McMahon M; Weinberg K; Bigler M; de Vries JE; Roncarolo MG
    Blood; 1995 Apr; 85(7):1944-53. PubMed ID: 7703497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe combined immunodeficiency: treatment by bone marrow transplantation in 15 infants using HLA-haploidentical donors.
    Friedrich W; Goldmann SF; Ebell W; Blütters-Sawatzki R; Gaedicke G; Raghavachar A; Peter HH; Belohradsky B; Kreth W; Kubanek B
    Eur J Pediatr; 1985 Jul; 144(2):125-30. PubMed ID: 3899661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Self-tolerance to host and donor following HLA-mismatched bone marrow transplantation.
    De Villartay JP; Griscelli C; Fischer A
    Eur J Immunol; 1986 Feb; 16(2):117-22. PubMed ID: 3514234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.